Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up

Gastrointestinal Endoscopy

Volumn 68, Issue 5, 2008, Pages 867-876

  Fleischer, David E ^a   Overholt, Bergein F ^a   Sharma, Virender K ^a   Reymunde, Alvaro ^a   Kimmey, Michael B ^a   Chuttani, Ram ^a   Chang, Kenneth J ^a   Lightdale, Charles J ^a   Santiago, Nilda ^a   Pleskow, Douglas K ^a   Dean, Patrick J ^a   Wang, Kenneth K ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CLINICAL TRIAL; COLUMNAR EPITHELIUM; ENDOSCOPIC SURGERY; ESOPHAGUS BIOPSY; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; REMISSION; SAFETY; UNITED STATES;

BARRETT ESOPHAGUS; BIOPSY, NEEDLE; CATHETER ABLATION; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 43849108800     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2008.03.008     Document Type: Article

References (35)

1. Peters J.H., Hagen J.A., and DeMeester S.R. Barrett's esophagus. J Gastrointest Surg 8 (2004) 1-17
2. Reid B.J. Barrett's esophagus and adenocarcinoma. Gastroenterol Clin North Am 20 (1991) 817-834
3. Shaheen N., and Ransohoff D.R. Gastroesophageal reflux, Barrett's esophagus and esophageal cancer. JAMA 287 (2002) 1972-1981
4. Cameron A.J., Zinsmeister A.R., Ballard D.J., et al. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 99 (1990) 918-922
5. Ronkainen J., Aro P., Storskrubb T., et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 129 (2005) 1825-1831
6. Rex D.K., Cummings O.W., Shaw M., et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125 (2003) 1670-1677
7. Gerson L.B., Shetler K., and Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 123 (2002) 636-639
8. Labenz J., Nocon M., Lind T., et al. Prospective follow-up data from the ProGERD Study suggest that GERD is not a categorical disease. Am J Gastroenterol 101 (2006) 2457-2462
9. Kendall B.J., and Whiteman D.C. Temporal changes in the endoscopic frequency of new cases of Barrett's esophagus in an Australian health region. Am J Gastroenterol 101 (2006) 1178-1182
10. Shaheen N.J. Advances in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 128 (2005) 1554-1566
11. Chandrosoma P., Wickramasinghe K., Ma Y., et al. Is intestinal metaplasia a necessary precursor lesion for adenocarcinoma of the distal esophagus, gastroesophageal junction and gastric junction?. Dis Esophagus 20 (2007) 36-41
12. Shaheen N.J., Crosby M.A., Bozymski E.M., et al. Is there a publication bias in reporting cancer risk in Barrett's esophagus?. Gastroenterology 119 (2000) 333-338
13. Sharma P., Falk G.W., Weston A.P., et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 4 (2006) 566-572
14. Drewitz D.J., Sampliner R.E., and Garewal H.S. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 92 (1997) 212-215
15. Rudolph R.E., Vaughan T.L., Storer B.E., et al. Effect of segment length on risk for neoplastic progression in patients with Barrett's esophagus. Ann Intern Med 132 (2000) 612-620
16. O'Connor J.B., Falk G.W., and Richter J.E. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol 94 (1999) 2037-2042
17. Robertson C.S., Mayberry J.F., Nicholson D.A., et al. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's esophagus. Br J Surg 75 (1988) 760-763
18. Hameeteman, Tytgat G.N., Houthoff H.J., et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 96 (1989) 1249-1256
19. Vaughan T.L., Dong L.M., Blount P.L., et al. Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. Lancet Oncol 6 (2005) 945-952
20. Sampliner R.E. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 97 (2002) 1888-1895
21. Overholt B.F., Lightdale C.J., Wang K.K., et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 62 (2005) 488-498
22. Webber J., Herman M., Kessel D., et al. Current concepts in gastrointestinal photodynamic therapy. Ann Surg 230 (1999) 12-23
23. Ell C., May A., Gossner L., et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 118 (2000) 670-677
24. Seewald S., Akaraviputh T., Seitz U., et al. Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 57 (2003) 854-859
25. Gossner L., May A., Stolte M., et al. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc 49 (1999) 8-12
26. Ginsberg G.G., Barkun A.N., Bosco J.J., et al. The argon plasma coagulator. Gastrointest Endosc 55 (2002) 807-810
27. Dulai G.S., Jensen D.M., Cortina G., et al. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointest Endosc 61 (2005) 232-240
28. Montes C.G., Brandalise N.A., Deliza R., et al. Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus. Gastrointest Endosc 50 (1999) 173-177
29. Sampliner R.E., Faigel D., Fennerty M.B., et al. Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest Endosc 53 (2001) 554-558
30. Johnston M.H., Eastone J.A., Horwhat J.D., et al. Cryoablation of Barrett's esophagus: a pilot study. Gastrointest Endosc 62 (2005) 842-848
31. Sharma V.K., Wang K.K., Overholt B.F., et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 65 (2007) 185-195
32. Ganz R.A., Utley D.S., Stern R.A., et al. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest Endosc 60 (2004) 1002-1010
33. Dunkin B.J., Martinez J., Bejarano P.A., et al. Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device (BÂRRX). Surg Endosc 20 (2006) 125-130
34. Smith C.D., Bejarano P.A., Melvin W.S., et al. Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system. Surg Endosc 21 (2007) 560-569
35. Shaheen N.J., Dulai G.S., Ascher B., et al. Effect of a new diagnosis of Barrett's esophagus on insurance status. Am J Gastro 100 (2005) 577-580